Efalizumab-induced immune thrombocytopenia during retreatment.
Fargnoli
Maria Concetta
MC
Tabilio
Antonio
A
Coletti
Gino
G
Peris
Ketty
K
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008297:Male; D010976:Platelet Count; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000276:immunology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab